In 2020, de Vries et al. [18] used SF-36 and pruritus VAS questionnaires to analyse the quality of life in patients with ABCB4 deficiency in comparison with PSC, PBC and the general population. This evidence concerns the gene ABCB4 and primary biliary cholangitis.